Articles by Disease (Hematological Malignancies)

Exploratory Study on the Effects of Biodegradable Nanoparticles with Drugs on Malignant B Cells and on a Human/Mouse Model of Burkitt Lymphoma

Journal: Current Clinical Pharmacology
Volume: 5
Page: 246-250
Author(s): Gustavo H. Marin, Eduardo Mansilla, Nelly Mezzaroba, Sonia Zorzet, Luis Nunez, Gustavo Larsen, Jose M. Tau, Alberto Maceira, Ruben Spretz, Carol Mertz, Sabrina Ingrao, Claudio Tripodo, Francesco Tedesco and Paolo Macor

Role of Glucocorticoids in Breast Cancer

Journal: Current Pharmaceutical Design
Volume: 16
Page: 3593-3600
Author(s): Jayant S. Vaidya, Gustavo Baldassarre, Mangesh A. Thorat and Samuele Massarut

FK506 Binding Proteins as Targets in Anticancer Therapy

Journal: Anti-Cancer Agents in Medicinal Chemistry
Volume: 10
Page: 651-656
Author(s): Simona Romano, AnnaLaura Di Pace, Antonio Sorrentino, Rita Bisogni, Luigi Sivero and Maria Fiammetta Romano

Therapeutic Antibodies in HIV Treatment - Classical Approaches to Novel Advances

Journal: Current Pharmaceutical Design
Volume: 16
Page: 3754-3766
Author(s): Irene A. Abela, Lucy Reynell and Alexandra Trkola

Aurora A and B Kinases - Targets of Novel Anticancer Drugs

Journal: Recent Patents on Anti-Cancer Drug Discovery
Volume: 5
Page: 219-241
Author(s): Silvana Libertini, Antonella Abagnale, Carmela Passaro, Ginevra Botta and Giuseppe Portella

Regulation of Apoptosis and Cell Survival by Resveratrol

Journal: Mini-Reviews in Organic Chemistry
Volume: 7
Page: 262-266
Author(s): Simone Fulda

Transcription Factor NF-κB Inhibitors as Single Therapeutic Agents or in Combination with Classical Chemotherapeutic Agents for the Treatment of Hematologic Malignancies

Journal: Current Molecular Pharmacology
Volume: 3
Page: 98-122
Author(s): Ota Fuchs